These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 3855323)

  • 1. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
    Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues.
    Fedyna JS; Adejare A; Miller DD; Feller DR
    Eur J Pharmacol; 1987 Mar; 135(2):161-71. PubMed ID: 2884118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.
    Romstedt KJ; Shin Y; Shams G; Doyle K; Tantishaiyakul V; Clark MT; Adejare A; Hamada A; Miller DD; Feller DR
    Biochem Pharmacol; 1993 Dec; 46(11):2051-9. PubMed ID: 8267653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
    Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR
    Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.
    Shams G; Romstedt KJ; Gerhardt MA; Harrold MW; Miller DD; Feller DR
    Eur J Pharmacol; 1990 Aug; 184(1):21-31. PubMed ID: 1976530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists.
    Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD
    Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
    Shin Y; Romstedt KJ; Doyle K; Harrold MW; Gerhardt MA; Miller DD; Patil PN; Feller DR
    Chirality; 1991; 3(2):112-7. PubMed ID: 1830752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
    Shin Y; Romstedt KJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists.
    Shams G; Wallace LJ; Miller DD; Feller DR
    Pharmacology; 1990; 40(1):27-32. PubMed ID: 2139513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of [3H]trimetoquinol as a radioligand in human platelets: interaction with putative endoperoxide/thromboxane A2 receptor sites.
    Ahn CH; Wallace LJ; Miller DD; Feller DR
    Thromb Res; 1988 May; 50(3):387-99. PubMed ID: 2969151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.
    Markovich KM; Tantishaiyakul V; Hamada A; Miller DD; Romstedt KJ; Shams G; Shin Y; Fraundorfer PF; Doyle K; Feller DR
    J Med Chem; 1992 Feb; 35(3):466-79. PubMed ID: 1346651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and beta-adrenergic agonist and antiaggregatory properties of N-substituted trimetoquinol analogues.
    Adejare A; Miller DD; Fedyna JS; Ahn CH; Feller DR
    J Med Chem; 1986 Sep; 29(9):1603-9. PubMed ID: 2875182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoquinol selectively antagonizes contractions of rat gastric fundus to TXB2 and epoxymethano analogs of PGH2.
    Sanger GJ; Bennett A
    Adv Prostaglandin Thromboxane Res; 1980; 8():1559-60. PubMed ID: 6103666
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M; Högestätt ED; Uski TK
    Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A; Shirakura S; Higo K; Kubo K
    Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
    J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs.
    Shams G; Romstedt KJ; Lust LA; Clark MT; Miller DD; Feller DR
    Gen Pharmacol; 1997 Feb; 28(2):323-30. PubMed ID: 9013212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.